Replimune Group Capital Expenditures (CapEx) Growth & History (REPL)
Replimune Group's capital expenditures (capex) was $4.2M for fiscal 2026.
View full Replimune Group company overviewReplimune Group annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $4.2M | −$2.5M | −36.85% |
| 2025 | 2025-03-31 | $6.7M | $1.0M | +18.10% |
| 2024 | 2024-03-31 | $5.7M | $3.4M | +149.43% |
| 2023 | 2023-03-31 | $2.3M | −$66,000 | −2.83% |
| 2022 | 2022-03-31 | $2.3M | −$56,000 | −2.34% |
| 2021 | 2021-03-31 | $2.4M | −$4.1M | −63.43% |
| 2020 | 2020-03-31 | $6.5M | $3.9M | +151.54% |
| 2019 | 2019-03-31 | $2.6M | $2.5M | +1811.76% |
| 2018 | 2018-03-31 | $136,000 | −$102,000 | −42.86% |
| 2017 | 2017-03-31 | $238,000 | — | — |
Replimune Group quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $6,000 | −$2.7M | −99.78% |
| Q4 2026 | 2026-03-31 | $5,000 | −$1.1M | −99.56% |
| Q3 2026 | 2025-12-31 | $135,000 | −$1.7M | −92.50% |
| Q2 2026 | 2025-09-30 | $1.3M | −$741,000 | −35.56% |
| Q1 2026 | 2025-06-30 | $2.7M | $1.1M | +64.17% |
| Q4 2025 | 2025-03-31 | $1.1M | −$606,000 | −34.83% |
| Q3 2025 | 2024-12-31 | $1.8M | $81,000 | +4.71% |
| Q2 2025 | 2024-09-30 | $2.1M | $330,000 | +18.81% |
| Q1 2025 | 2024-06-30 | $1.7M | $1.2M | +271.71% |
| Q4 2024 | 2024-03-31 | $1.7M | $1.5M | +593.23% |
| Q3 2024 | 2023-12-31 | $1.7M | $1.2M | +209.73% |
| Q2 2024 | 2023-09-30 | $1.8M | $1.4M | +342.93% |
| Q1 2024 | 2023-06-30 | $449,000 | −$619,000 | −57.96% |
| Q4 2023 | 2023-03-31 | $251,000 | −$901,000 | −78.21% |
| Q3 2023 | 2022-12-31 | $555,000 | $90,000 | +19.35% |
| Q2 2023 | 2022-09-30 | $396,000 | −$32,000 | −7.48% |
| Q1 2023 | 2022-06-30 | $1.1M | $777,000 | +267.01% |
| Q4 2022 | 2022-03-31 | $1.2M | $382,000 | +49.61% |
| Q3 2022 | 2021-12-31 | $465,000 | −$150,000 | −24.39% |
| Q2 2022 | 2021-09-30 | $428,000 | $353,000 | +470.67% |
| Q1 2022 | 2021-06-30 | $291,000 | −$641,000 | −68.78% |
| Q4 2021 | 2021-03-31 | $770,000 | −$568,000 | −42.45% |
| Q3 2021 | 2020-12-31 | $615,000 | −$3.4M | −84.84% |
| Q2 2021 | 2020-09-30 | $75,000 | −$709,000 | −90.43% |
| Q1 2021 | 2020-06-30 | $932,000 | $570,000 | +157.46% |
| Q4 2020 | 2020-03-31 | $1.3M | −$510,000 | −27.60% |
| Q3 2020 | 2019-12-31 | $4.1M | $3.4M | +540.76% |
| Q2 2020 | 2019-09-30 | $784,000 | $781,000 | +26033.33% |
| Q1 2020 | 2019-06-30 | $362,000 | $246,000 | +212.07% |
| Q4 2019 | 2019-03-31 | $1.8M | $1.8M | +46100.00% |
| Q3 2019 | 2018-12-31 | $633,000 | $627,000 | +10450.00% |
| Q2 2019 | 2018-09-30 | $3,000 | −$98,000 | −97.03% |
| Q1 2019 | 2018-06-30 | $116,000 | $83,000 | +251.52% |
| Q4 2018 | 2018-03-31 | $4,000 | — | — |
| Q3 2018 | 2017-12-31 | $6,000 | — | — |
| Q2 2018 | 2017-09-30 | $101,000 | — | — |
| Q1 2018 | 2017-06-30 | $33,000 | — | — |
Replimune Group capital expenditures (capex) trends
Over the last five fiscal years, Replimune Group's capital expenditures (capex) increased from $2.4M to $4.2M, a change of $1.8M. The latest reported quarter, Q1 2027, shows $6,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Replimune Group source filings ↗